Maraviroc influence on gut microbiome in HIV-infected individuals

Trial Profile

Maraviroc influence on gut microbiome in HIV-infected individuals

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Nov 2016

At a glance

  • Drugs Maraviroc (Primary) ; Atazanavir; Emtricitabine/tenofovir; Ritonavir
  • Indications HIV infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 18 May 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top